The Purkinje cell degeneration (pcd) mouse is a recessive model of neurodegeneration, involving cerebellum and retina. Purkinje cell death in pcd is dramatic, as >99% of Purkinje neurons are lost in 3 weeks. Loss of function of Nna1 causes pcd, and Nna1 is a highly conserved zinc carboxypeptidase. To determine the basis of pcd, we implemented a two-pronged approach, combining characterization of loss-of-function phenotypes of the Drosophila Nna1 ortholog (NnaD) with proteomics analysis of pcd mice. Reduced NnaD function yielded larval lethality, with survivors displaying phenotypes that mirror disease in pcd. Quantitative proteomics revealed expression alterations for glycolytic and oxidative phosphorylation enzymes. Nna proteins localize to mitochondria, loss of NnaD/Nna1 produces mitochondrial abnormalities, and pcd mice display altered proteolytic processing of Nna1 interacting proteins. Our studies indicate that Nna1 loss of function results in altered bioenergetics and mitochondrial dysfunction.
The Purkinje cell degeneration (pcd) mouse is a recessive model of neurodegeneration, involving cerebellum and retina. Purkinje cell death in pcd is dramatic, as >99% of Purkinje neurons are lost in 3 weeks. Loss of function of Nna1 causes pcd, and Nna1 is a highly conserved zinc carboxypeptidase. To determine the basis of pcd, we implemented a two-pronged approach, combining characterization of loss-of-function phenotypes of the Drosophila Nna1 ortholog (NnaD) with proteomics analysis of pcd mice. Reduced NnaD function yielded larval lethality, with survivors displaying phenotypes that mirror disease in pcd. Quantitative proteomics revealed expression alterations for glycolytic and oxidative phosphorylation enzymes. Nna proteins localize to mitochondria, loss of NnaD/Nna1 produces mitochondrial abnormalities, and pcd mice display altered proteolytic processing of Nna1 interacting proteins. Our studies indicate that Nna1 loss of function results in altered bioenergetics and mitochondrial dysfunction.
INTRODUCTION
In 1976, workers at the Jackson Laboratory reported the discovery of a novel neurological phenotype that was inherited in a Mendelian fashion (Mullen et al., 1976) . They labeled this new mutant ''Purkinje cell degeneration'' and determined that it was inherited as an autosomal-recessive trait, assigning it a locus pcd. The original pcd mice (now known as pcd-1J to distinguish them from later occurring pcd mutations) display a stereotypical phenotype (Mullen et al., 1976) . Indeed, most of the pcd alleles, including 1J, 3J, and 5J, yield this severe phenotype (Chakrabarti et al., 2006) . At weaning at postnatal day 21 (P21), pcd mice have a problem with coordinated movement, showing awkwardness when ambulating. By 4 weeks of age, pcd mice have pronounced gait ataxia. This gait ataxia is progressive, becoming severe by 6 weeks, but not progressing further in the course of their lifetime. Careful histopathological analysis of the brains of pcd mice revealed a remarkable degenerative phenotype; pcd mice begin with a normal complement of Purkinje cells and normal cerebellar cytoarchitecure at P15 but are subject to a rapidly progressive degeneration and loss of >99% of their Purkinje cells in just 3 weeks, typically by P35 (Mullen et al., 1976) . Another feature of the pcd phenotype is retinal degeneration. Histology studies of pcd mice indicate that the retinal degeneration primarily involves the photoreceptor cells (LaVail et al., 1982) . By 2-3 months of age, most pcd mice show mild thinning of the outer nuclear layer (ONL) due to loss of photoreceptor nuclei. By 6 months of age, the loss of photoreceptor cells is marked, and, by 10.5 months of age, the ONL is nearly bereft of photoreceptors.
Recombinant mapping by directed breeding, followed by evaluation of candidate genes from the critical region, led to identification of Nna1 as the causal gene for pcd (FernandezGonzalez et al., 2002) . The Nna1 protein is 1218 amino acids in length and possesses a number of different putative functional domains, including a conserved zinc carboxypeptidase (ZnCP) domain contained within a region spanning amino acids 870-1070. Nna1 has been highly conserved evolutionarily, as a previously anonymous gene (KIAA1035) with 82% identity in its amino acid coding region is the human ortholog (NNA1), single orthologs exist in Drosophila melanogaster and Zymomonas mobilis, and two Nna1 homologs occur in Caenorhabditis elegans (Harris et al., 2000) . While some homologs contain putative nuclear localization signals and ATP/GTP binding sites, only the ZnCP domain is conserved in all Nna1 homologs (Harris et al., 2000; Rodriguez de la Vega et al., 2007) . Further sequence analysis of the mouse genome and of other divergent species suggests that Nna1-like proteins comprise a novel subfamily of carboxypeptidases (Kalinina et al., 2007) . The importance of Nna1 enzymatic function for pcd was demonstrated by rescue studies in which normal transgenic Nna1 could complement homozygous pcd mice, but catalytically dead Nna1 could not (Chakrabarti et al., 2008; Wang et al., 2006) .
Although there is good reason to believe that Nna1 ZnCP function is crucial for neuronal survival in pcd (Chakrabarti et al., 2008; Wang et al., 2006) , and also for neuron regeneration after injury (Harris et al., 2000) , neither the target substrates for Nna1 action nor the molecular pathways regulated by Nna1 are known. The fruit fly, Drosophila melanogaster, has proved to be a powerful system for modeling neurological phenotypes and defining mechanistic pathways for gene products of unknown function. As a highly conserved ortholog of Nna1 exists in flies, we reasoned that mutation of the Drosophila Nna1 ortholog (known as NnaD) and study of the resultant phenotypes might shed light on the function of Nna1. Toward that end, we characterized a loss-of-function allele of Drosophila NnaD and discovered that reduced NnaD function yields a semilethal phenotype, with survivors displaying a range of phenotypes that mirror the disease pathology observed in pcd mice. To define potential pathways affected by Nna1 loss of function in pcd mice, we also performed a quantitative comparative analysis of the pcd retinal proteome and noted significant alterations for enzymes of glycolysis and oxidative phosphorylation. Further studies of NnaD in Drosophila and Nna1 in pcd mice indicated that Nna proteins localize to mitochondria and that loss of Nna carboxypeptidase function results in morphological and functional mitochondrial abnormalities, including diminished respiratory chain complex activities, corroborating the mitochondrial dysfunction suggested by our recent observation of increased mitochondrial autophagy in pcd mice (Chakrabarti et al., 2009) . Mass spectrometry analysis of the Nna1 interactome in cerebellar tissue confirmed the relationship of Nna1 to bioenergetics processes and uncovered an interacting protein with altered proteolytic processing in pcd mice. These data suggest that the Nna1 family of proteins play an important role in maintaining normal mitochondrial function, and that pcd phenotypes may have a mitochondrial basis.
RESULTS

Molecular
Characterization of a Drosophila Ortholog of the Mouse Nna1 Gene Analysis of Drosophila genome sequence revealed the existence of a single ortholog of the mouse Nna1 gene (CG32627; NnaD). Overall, the NnaD protein is 48% similar and 25% identical to the mouse Nna1 protein; however, the conservation is much higher in the carboxypeptidase domain (59% similar and 41% identical). The NnaD locus spans 19 kb on the Drosophila X chromosome and is contained within another gene (the nicotinamide adenine dinucleotide synthesis gene), with the coding regions for the NnaD gene and the nicotinamide adenine dinucleotide synthesis gene lying in opposite orientation ( Figure 1A ). All three transcripts predicted from the NnaD locus contain the carboxypeptidase motif. Although northern blot analysis of embryos did not detect any NnaD transcripts, an 3.5 kb transcript, corresponding to the NnaD-RB transcript, was detected in larvae and adults and confirmed by RT-PCR analysis ( Figure S1A ). To characterize the spatial expression pattern of NnaD at the protein level, we generated rabbit polyclonal NnaD antibodies against a GST fusion protein containing the final 95 amino acid residues (843-937) from the highly conserved carboxy-terminal region. One of these antisera, which we designated as antibody ''Z,'' recognized a protein corresponding to full-length NnaD in Tub.GAL4/UAS.NnaD-RB adult flies on western blot analysis; however, endogenous expression of NnaD is low, precluding its detection in wild-type controls (Figure S1B) . To determine the spatial expression pattern of NnaD, we derived NnaD.GAL4 transgenic driver lines by fusing 1.3 kb of the putative NnaD promoter to yeast GAL4 and then crossed the resulting NnaD.GAL4 flies with UAS.GFP reporter flies. The fluorescence pattern in NnaD.GAL4/UAS.GFP larvae revealed prominent staining in the brain, optic lobes, and ventral ganglia ( Figure 1B ).
Flies Bearing a P Element Insertion in the NnaD Gene Exhibit a Semilethal Phenotype
In a screen for novel lethal mutations on the X chromosome, Bourbon et al. reported reduced viability in a Drosophila strain carrying a P element insertion in the NnaD locus (NnaD PL90 ;
see Figure 1A ) (Bourbon et al., 2002) . We obtained this Drosophila strain, which we designated as the NnaD PL90 line, and observed a marked reduction in NnaD mRNA expression in NnaD PL90 larvae upon semiquantitative RT-PCR analysis (Figure S1C ). This marked reduction in NnaD mRNA expression was confirmed by real-time RT-PCR and quantified at 8% of the NnaD mRNA expression level in control flies. Using this same approach, we measured the expression level of the nicotinamide adenine dinucleotide synthesis gene and noted a reduction of 52% in its expression. We began our analysis of NnaD PL90 lethality by generating female flies heterozygous for the P element insertion. We documented expected numbers of female NnaD PL90 progeny from such crosses (data not shown), allowing us to conclude that haploinsufficiency at the NnaD-nicotinamide adenine dinucleotide synthesis gene locus is compatible with a normal phenotype. Analysis of NnaD PL90 male flies, however, revealed an entirely different outcome. Although NnaD PL90 mutants hatch from their eggs in normal numbers with no defects in cuticle patterning, we noted that NnaD PL90 third instar larvae are much thinner than their control siblings ( Figure S1D ). Figure 1C ). As a common feature of Drosophila neurodegenerative mutant flies is shortened lifespan (Marsh and Thompson, 2006) , we compared the survival of NnaD PL90 escaper males with FM7 siblings, yellow (yw) male controls, and male flies derived by precise excision of the NnaD gene P element, and we noted a marked reduction in survival in NnaD PL90 escaper males ( Figure 1D (Chakrabarti et al., 2006; Mullen et al., 1976) . To determine whether loss of NnaD function similarly results in neurodegeneration in Drosophila, we examined thin sections of NnaD PL90 adult heads for evidence of degeneration. Although there was no evidence of vacuolization or gross neurodegeneration in the brain parenchyma of 18-day-old NnaD PL90 males, we did observe prominent areas of thinning, cell loss, and vacuole formation in retinal photoreceptor neurons (Figures 2A-2D ). When we examined 2-day-old NnaD PL90 adult heads, we noted less severe photoreceptor degeneration ( Figure S2 ), indicating that the retinal degeneration is progressive in nature. To further characterize the retinal degeneration phenotype of NnaD PL90 escaper males, we examined thin sections of NnaD PL90 mutant retinas and control retinas by transmission electron microscopy. In normal retinas, the photoreceptors were arranged in a paracrystalline array of ommatidia, with all ommatidia displaying stereotypical cytoarchitecture ( Figure 2E ). In 5-day-old NnaD PL90 escaper males, however, the expected ommatidial array was severely disrupted ( Figure 2F ). Figure 2G ).
While assessment of degenerative morphology is a useful method for gauging phenotypic severity and rescue, evaluation of visual function is also informative. We thus tested NnaD PL90 escaper males for blindness using the Benzer countercurrent assay for phototaxis (Benzer, 1967) and noted that 4-day-old NnaD PL90 males scored extremely poorly (mean score = 0.61) ( Figure 2H ). When we derived NnaD PL90 escaper males carrying eye.GAL4/UAS.NnaD-RB, we observed significant rescue of the blindness phenotype (mean score = 3.09). Such rescue was not observed when we substituted the UAS.GFP transgene for UAS.NnaD-RB but was achieved when we instead used the UAS.p35 transgene ( Figure 2H ), indicating that altered apoptotic pathway activity is contributing to the NnaD PL90 escaper male retinal phenotype (and to the larval lethality, see Table 1 ). Although complete rescue by transgenic expression of NnaD indicates that NnaD PL90 loss-of-function phenotypes do not likely result from concomitant impairment in the gene for nicotinamide adenine dinucleotide synthesis, we obtained an RNAi line (GD7301) for NnaD and studied its phototaxis response. We found that NnaD RNAi flies performed very poorly on the Benzer assay ( Figure 2H ), confirming that the retinal degeneration phenotype in NnaD PL90 flies results from loss of function of NnaD.
Quantitative Proteomics Analysis of pcd Mouse Retinal Proteins
To identify which cellular pathways are involved in pcd neurodegeneration, we initiated a proteomics study to identify changes in protein abundance in tissues affected in pcd mice. For this experiment, we chose to focus upon the retina, since retinal degeneration is a key phenotypic feature in pcd mice, and the retina is among the least complex of all nervous system tissues. After we fractionated protein lysates from retinas dissected from 8-week-old presymptomatic pcd 5J mice and age-matched littermate controls ( Figure S3 ), we measured the abundance of all detected proteins using the peptide prophet score (Liu et al., 2004; Old et al., 2005) and calculated a ratio for relative abundance between pcd 5J and control samples. Gene ontology (GO) analysis indicated that a number of functional categories within the biological process, cellular compartment, and molecular function GO groups displayed significant protein expression alterations in the pcd 5J retina (Table S1 ). To generate a high-confidence list of proteins whose expression levels differed significantly between the pcd retinome and wild-type retinome, we screened the list for highly abundant proteins (scoring R15) with p value limits %0.05 to obtain the functional categories with the greatest number of abundant, significantly altered proteins and identified the ''glucose catabolic process,'' ''translation,'' and ''oxidative phosphorylation'' categories (Table 2 ). This analysis indicated that ''glucose catabolic process'' (i.e., glycolysis) is the most highly represented category, with six highly abundant, significantly altered proteins. As the oxidative phosphorylation category is also among the most highly represented groups undergoing protein expression level alteration (Table 2) , the quantitative proteomics analysis indicates that loss of function of Nna1 may perturb bioenergetics pathways.
Mitochondrial Morphology Is Altered in NnaD PL90 Escaper Males and pcd Mice
Alterations in the expression levels of metabolic enzymes in pcd mice led us to consider the role of the mitochondria in Nna loss-of-function neurodegeneration. To evaluate the status of mitochondria in NnaD PL90 flies, we performed electron microscopy analysis on 7-day-old NnaD PL90 escaper males and discovered a variety of striking ultrastructural abnormalities in the retina. As is typical of cells undergoing apoptosis, we noted many electron-dense degenerating retinal cells and identified endoplasmic reticulum (ER) regions highly studded with ribosomes in neurons at moderate to advanced stages of degeneration ( Figures 3A and 3B ). We then chose to focus upon retinal neurons whose cytosol had not yet become electron dense. When we examined the ultrastructural morphology of such NnaD PL90 retinal cells, we observed marked changes in mitochondrial morphology. Unlike control mitochondria with welldefined cristae and lumens of uniform size ( Figure 3C ), NnaD PL90 mitochondria had decreased numbers of cristae, and the lumens of the cristae were swollen and irregular ( Figure 3D ). Furthermore, many NnaD PL90 mitochondria had vacuoles, a feature never seen in control mitochondria. Using a scoring system devised to judge the degree of mitochondrial abnormality, we performed a quantitative analysis and documented that NnaD PL90 mitochondria are significantly more abnormal in their appearance ( Figure 3E ). We then compared mitochondria from the cerebellum of pcd 5J mice with those of age-matched heterozygous controls ( Figure 3F ) and also observed ER swelling and abnormal mitochondrial morphology in pcd 5J mice (Figure 3G ). We noted that pcd 5J mitochondria contained vacuoles and lacked distinct cristae ( Figure 3H ), findings highly reminiscent of mitochondria in NnaD PL90 escaper males. These ultrastructural abnormalities, detected in mutant flies at 7 days of age and in pcd mice prior to weaning, indicate that altered mitochondrial morphology is an early sign of neurodegeneration in both NnaD PL90 flies and pcd mice. Figure S2 .)
of NnaD with Mitotracker in transfected cells ( Figure 4B ). To determine if NnaD loss of function affects the mitochondrial oxidative phosphorylation pathway, we prepared third instar larvae mitochondrial extracts from normal yw controls, from NnaD PL90 mutants, and from FM7 controls. When we assayed complex I, complex II, and complex V activities (three of the complexes that comprise the oxidation phosphorylation pathway), we noted marked reductions in the activity of these mitochondrial complexes in NnaD PL90 larval samples ( Figure 4C ).
To assess the significance of reduced oxidative phosphorylation pathway function in vivo, we tested the ability of 7-day-old NnaD PL90 escaper males to tolerate two different mitochondrial poisons, 2,4-dinitrophenol (2,4-DNP) and oligomycin. Both 2,4-DNP and oligomycin inhibit ATP production: 2,4-DNP dissipates the proton gradient across the inner mitochondrial membrane, while oligomycin interferes with electron transfer in the respiratory chain. NnaD PL90 flies exhibited significantly decreased survival when exposed to 2,4-DNP at either a high concentration or low concentration ( Figure 4D ). In the case of oligomycin, NnaD PL90 escaper males were exquisitely susceptible to oligomycin at high concentrations, but, at low concentrations, both NnaD PL90 flies and FM7 controls were resistant ( Figure 4E ), suggesting a distinct threshold for toxicity. Hence, both biochemical assay measurements and in vivo mitochondrial toxicity testing indicate that loss of NnaD function yields pronounced mitochondrial dysfunction in the NnaD PL90 fly model.
To determine if Nna1 localizes to mitochondria and if metabolic abnormalities exist in pcd mice, we pursued a similar line of investigation for mouse Nna1 protein. When we performed MitoProtII analysis of the Nna1 amino acid sequence, we found that Nna1 also has a reasonable probability (37.4%) of being imported into mitochondria. To test if Nna1 is present in mitochondria, we prepared protein lysates from rat brain and spinal cord and fractionated the protein lysates by high-speed centrifugation. We then immunoblotted the mitochondrial and cytosolic fractions with a polyclonal anti-Nna1 antibody (''A'') developed by our group (Chakrabarti et al., 2006) , and we detected a prominent band for Nna1 protein in the brain mitochondrial fraction ( Figure 5A ). Interestingly, while Nna1 was present in the cytosolic fractions of both brain and spinal cord, Nna1 was absent from the spinal cord mitochondrial fraction ( Figure 5A ). Absence of Nna1 from spinal cord mitochondria correlates with normal motor neuron and sensory neuron function in pcd mice (Mullen et al., 1976) . To further define Nna1 mitochondrial localization, we performed a submitochondrial fractionation experiment and determined that Nna1 is enriched in the outer membrane of the mitochondria ( Figure 5B ). To test if loss of Nna1 function affects mitochondrial oxidative phosphorylation akin to what was observed in the NnaD PL90 fly model, we performed differential centrifugation to isolate mitochondrial fractions from the cerebella of pcd 5J and control mice and then measured the complex I activity. Mitochondrial fractions from pcd 5J mice exhibited significantly less complex I activity than matched samples from control mice ( Figure 5C ), indicating that loss of Nna1 does impair mitochondrial metabolic function.
Nna1 Interactome Analysis Yields Metabolic Enzymes with Altered Function and Processing
As pcd 5J mice exhibit altered protein expression levels for a variety of glycolytic and oxidative phosphorylation pathway enzymes (Table 2) and Nna1 localizes to mitochondria, we decided to survey the Nna1 interactome. Nna1 contains a ZnCP domain and may be involved in processing of proteins (Kalinina et al., 2007; Rodriguez de la Vega et al., 2007) ; hence, we reasoned that Nna1 protein lacking enzymatic activity should remain more tightly bound to potential substrate proteins, whose processing could not occur. As a previous yeast two-hybrid screen of ataxia-causing proteins did not yield putative interactors for Nna1 (Lim et al., 2006) , we decided to identify Nna1-interacting proteins in vivo and derived transgenic mice that ubiquitously overexpress myc-tagged Nna1 protein, using the CAGGS expression vector (Niwa et al., 1991) . We also derived transgenic mice that ubiquitously overexpress myc-tagged Nna1 protein with a mutant zinc-coordinating domain (MuZn) by substituting alanines for histidine 912 and glutamic acid 915 in the HXXE zinc-coordination consensus sequence of Nna1 Please see also Figure S3 and Table S1 .
Neuron
Mitochondrial Defects in NnaD Flies and pcd Mice (Joshi and St Leger, 1999; Karlin and Zhu, 1997) . We thus generated CAGGS-Nna1-wt and CAGGS-Nna1-MuZn transgenic mice and confirmed transgene expression ( Figure S4 ). We then performed immunoprecipitations of cerebellar protein lysates with an anti-myc antibody, subjected the immunoprecipitated proteins to mass spectrometry peptide sequencing, and generated a list of proteins found in common for each sample set. To ensure the specificity of identified proteins, we performed a series of control immunoprecipitations and subtracted proteins obtained from control samples, or with control antibodies (Table  S2) , to derive lists of proteins interacting with Nna1-wt or Nna1-MuZn (Table 3) . One of these proteins, phosphoglycerate mutase I, had also been identified in our quantitative proteomics analysis (Table 2 ). To assess the biological significance of this finding, we performed enzymatic assays on retinal lysates from pcd 5J and littermate control mice and noted markedly increased phosphoglycerate mutase activity ( Figure 5D ), consistent with the elevated expression detected in the quantitative proteomics analysis (Table 2) . We then measured pyruvate kinase activity, as this is a key step in the glycolytic pathway, and we found significantly decreased pyruvate kinase activity in pcd 5J extracts ( Figure 5E ), corroborating the expression alterations detected in the proteomics comparative analysis. When we considered the list of proteins interacting specifically with Nna1-MuZn, we again noted a number of glycolytic pathway enzymes. Such proteins are potential substrates for Nna1 carboxypeptidase action, as release of proteolytic substrate from enzymatically dead Nna1-MuZn protein would be retarded. To determine if such interacting proteins might be subject to Nna1 proteolytic cleavage, we performed immunoblot analysis of a subset of the Nna1-MuZn interactors and found evidence for proteolytic processing of aldolase A in cerebellar protein lysates from wild-type mice ( Figure 5F ). The cleaved isoform of aldolase A, however, was barely detectable in cerebellar protein lysates from pcd 5J mice, despite the fact that aldolase A appeared to be more abundant in pcd 5J cerebellum ( Figure 5F ). The cell at the upper right (black arrow) has a normal-looking rhabdomere (top right corner) and cytoplasm with normal density. However, the cell immediately below it has darkened cytoplasm, a vacuolated nucleus, and a large, ribosome-studded endoplasmic reticulum lamellar structure (white arrow). Note that the cell marked with an asterisk is severely degenerated. Scale bar, 2 mm. (C) In this higher-power view of the ommatidia shown in (A), numerous mitochondria are observed, all with well-defined cristae and of fairly uniform size. Scale bar, 500 nm. (D) In this higher-power view of the most normal ommatidium shown in (B) (black arrow), ultrastructural analysis confirms that profound anomalies are not yet present. However, careful inspection of this micrograph reveals mitochondria of reduced electron density (when compared to C). These mitochondria also display poorly defined, irregular, swollen cristae, with occasional vacuolation, indicating that mitochondrial ultrastructural abnormalities occur early in degenerating NnaD PL90 retina. Scale bar, 500 nm.
(E) Quantification of mitochondrial ultrastructural abnormalities in the fly eye. We compared the mitochondria of NnaD PL90 escaper males and their FM7 control siblings by grading electron density, degree of swelling, amount of vacuole formation, and extent of membrane damage and then used the combined score to categorize an individual mitochondrion as normal, moderately abnormal, or severely abnormal (n R 4 micrographs/region; n R 4 regions per individual; n = 5 per genotype). The mitochondria in the retinae of NnaD PL90 flies displayed significantly more structural abnormalities than control flies (p < 0.05, Mann-Whitney U-test). Error bars = SD. (F) Electron micrograph of a Purkinje cell body and nucleus (Nu) from a wildtype 3-week-old mouse reveals a nuclear compartment of normal electron density with well-demarcated boundaries. The perinuclear region contains normal ER and abundant normal mitochondria. Scale bar, 2 mm.
(G) Electron micrograph of a Purkinje cell body and nucleus (Nu) from a 3-week-old pcd mouse demonstrates a number of ultrastructural abnormalities. The nucleus is considerably electron dense and has poorly defined boundaries. ER is swollen (black arrow), and many mitochondria have unusual morphologies, including occasional enlarged, vacuolated mitochondria (white arrow). Scale bar, 2 mm.
(H) Electron micrograph of a Purkinje cell body and nucleus (Nu) from a different 3-week-old pcd mouse again reveals ultrastructrual abnormalities, including vacuole formation (asterisk) and numerous mitochondria with poorly defined cristae (black arrows). Scale bar, 2 mm.
DISCUSSION
The molecular pathways involved in neuron cell death in many neurodegenerative diseases remain shrouded in mystery (Clarke et al., 2000; Conforti et al., 2007) . Numerous studies have evaluated end-stage material from patients with Alzheimer's disease, Parkinson's disease, and Huntington's disease, but these studies have failed to yield definitive evidence of apoptotic cell death, or other processes of cell death, as the basis for the neuron loss (Jellinger, 2006) . Indeed, as adult neurons are wired into complex circuits in the CNS, redundant ''brakes'' have been placed upon neuron cell death, since replacement of such neurons and integration of new neurons into these complex circuits may not be possible. The pcd mouse model offers an opportunity to understand how neuron cell death occurs in different neuronal cell types, as pcd mice display a phenotype of Purkinje cell death and retinal photoreceptor loss (Mullen et al., 1976) . Purkinje cell death in pcd is among the most dramatic examples of postdevelopmental neuron cell death, as pcd mice have all their cerebellar Purkinje cells at 2 weeks of age, but then suffer a cataclysmic Purkinje cell degeneration, culminating in the death of >99% of their Purkinje neurons by 5 weeks of age. For these reasons, we sought the genetic cause of the pcd phenotype and identified loss of function of the Nna1 gene as the basis of pcd (FernandezGonzalez et al., 2002) . As Nna1 had already been characterized in a study seeking genes involved in regeneration from nerve injury (Harris et al., 2000) , the assignment of the Nna1 gene as the cause of the pcd phenotype confirmed the importance of Nna1 for neuron survival. However, as the normal function of Nna1 and the molecular pathways that it regulates are unknown, the mechanisms by which Nna1 loss-of-function leads to neurodegeneration and neuron cell death remain undefined. In this study, we implemented a two-pronged approach to gain insight into the molecular basis of pcd neurodegeneration, controls (n = 10-20/group) were reared on oligomycin mixed into their food at a concentration of either 0.03% or 0.003%. NnaD PL90 flies displayed significantly reduced viability at high concentrations of oligomycin (p < 0.05, Fisher's exact test), but minimal lethal toxicity was noted for the low oligomycin concentration.
combining characterization of phenotypes resulting from loss of function of the Drosophila Nna1 ortholog (NnaD) with an unbiased proteomics analysis of pcd retinal degeneration and Nna1.
As the NnaD gene is on the Drosophila X chromosome, we obtained a strain of flies (PL90) carrying a P element insertion in the NnaD gene (Bourbon et al., 2002) , and, after confirming that most male NnaD PL90 individuals suffer larval lethality, we attributed this NnaD PL90 larval lethality to inactivation of NnaD, since transgenic expression of NnaD fully rescued the lethality phenotype. As larval lethality due to NnaD loss of function in NnaD PL90 flies is not fully penetrant, we obtained frequent Using a quantitative proteomics approach, we compared protein expression profiles of retinas from sets of presymptomatic pcd mice and wild-type littermates. This experiment, which utilized retina as the study tissue due to its preponderance of photoreceptor neurons, and relied upon the spectral counting method (Liu et al., 2004; Old et al., 2005) , yielded a set of proteins highly enriched for enzymes of the glycolytic and oxidative phosphorylation pathways. While most metabolic enzymes identified in this quantitative proteomics analysis were increased in expression in the retinas of presymptomatic pcd mice, key Student's t test). (E) Decreased pyruvate kinase activity in pcd retina. Assay of pyruvate kinase activity on retinal extracts from wild-type (wt) and pcd 5J (pcd-5J) mice revealed a significant decrease in pyruvate kinase activity for the pcd 5J samples (p < 0.05; Student's t test).
(F) Aldolase A levels and proteolytic processing are altered in pcd cerebellum. We immunoblotted cerebellar lysates from two sets of 2-week-old wild-type (wt) and pcd 5J mice with an anti-aldolase A antibody. While overall levels of aldolase A appear elevated in pcd 5J , proteolytic processing of aldolase A to a lower migrating isoform is markedly reduced in pcd 5J cerebellum. (See also Figure S5 . ) terminal enzymes were decreased. Pyruvate kinase, which catalyzes irreversible formation of pyruvate from phosphoenolpyruvate, was decreased in pcd retina. As pyruvate kinase is an important regulatory step for glycolysis and controls outflow from this pathway, decreased pyruvate kinase activity, which we biochemically confirmed, will inevitably result in decreased energy production. Impairment of glucose utilization has important implications for neuron loss in pcd, as glucose is the major fuel source for neurons (Funari et al., 2007) . Concomitant increases in glycolytic pathway enzymes upstream of pyruvate kinase were detected in pcd retina (Table 2 ). Such increases typically occur when distal enzymatic steps in glycolysis are blocked (Svirklys and O'Sullivan, 1980) and further support the conclusion that reductions in pyruvate kinase levels and activity have functional consequences. Upregulation of mitochondrial oxidative phosphorylation enzymes may similarly represent an attempt by pcd neurons to counter the resulting energy deficit, as molecular pathways involving regulatory transcription factors, such as PPARg coactivator 1a (PGC-1a), are capable of increasing mitochondrial number and enzyme concentrations in neurons in response to bioenergetics stress (Houten and Auwerx, 2004; Wu et al., 1999) . Although the Nna1 protein is a putative zinc carboxypeptidase (ZnCP) (Harris et al., 2000; Kalinina et al., 2007; Rodriguez de la Vega et al., 2007) , the Nna1 gene product has a number of other functional domains. Extremely high conservation of the ZnCP domain and recent studies demonstrating that mutant Nna1 protein, lacking enzymatic activity, is incapable of rescuing pcd cerebellar and retinal degeneration, however, have implicated Nna1's ZnCP domain as crucial for its prosurvival function (Chakrabarti et al., 2008; Wang et al., 2006) . Despite this advance, Nna1 substrates, Nna1-regulated molecular pathways, and the basis of Nna1's neuron survival function remain undefined. Our studies of NnaD and Nna1 suggest that Nna family proteins function in mitochondria. Amino acid sequence analysis of NnaD and Nna1 revealed a putative mitochondrial targeting sequence. We found that NnaD localizes to mitochondria upon transfection into Drosophila S2 cells or HEK293T cells, and that Nna1 is present in mitochondrial fractions from rodent brain. We then performed submitochondrial localization of Nna1 and demonstrated that Nna1 is enriched in the mitochondrial outer membrane. Nna1 is part of a large family of genes, all of which contain a highly conserved ZnCP domain (Harris et al., 2000; Rodriguez de la Vega et al., 2007 ). An extensive genomic study, that included the analysis of genomes from bacteria, protista, and animalia, uncovered >100 Nna1 orthologs (Rodriguez de la Vega et al., 2007) . Most eukaryotic genomes contain several Nna1 paralogues. D. melanogaster possesses a single Nna1 ortholog (NnaD), C. elegans has a pair of Nna1-like orthologs, while mouse and human genomes each have six. In vitro examination of recombinant C. elegans Nna1-like protein revealed that it can remove a variety of C-terminal amino acids from synthetic peptides (Rodriguez de la Vega et al., 2007) ; however, a Z-glutamic acid-tyrosine (Z-Glu-Tyr) dipeptide was the best competitive inhibitor (Rodriguez de la Vega et al., 2007) . Thus, Nna1 may bind proteins and enzymes and process them by endopeptidase cleavage. When we tested this hypothesis by immunoblotting Nna1 protein interactors identified by mass spectrometry analysis, we found that aldolase A is proteolytically processed in control mice, but not in pcd 5J mice. As the final residue in aldolase A is a tyrosine, this observation is consistent with Nna1 possessing tyrosine carboxypeptidase activity. Furthermore, in wild-type mice, mitral neurons express both a tyrosinated and detyrosinated form of a-tubulin, while the pcd-3J mice only express the tyrosinated form of a-tubulin, suggesting deficient detyrosination in mutant mitral cells (Kalinina et al., 2007) . Thus, loss of Nna1 may lead to neurodegeneration by incomplete or improper endopeptidase processing of certain substrates.
Our discovery of altered metabolic enzyme levels and a pyruvate kinase deficiency in pcd mice suggests that impaired bioenergetics is involved in pcd neurodegeneration. As our studies of the NnaD PL90 fly model implicated apoptotic activation in the retinal degeneration, we performed ultrastructural analysis of neurons in the retina and observed profound abnormalities in the morphology of mitochondria, even in neurons whose cytosol Please see also Figure S4 and Table S2 .
was yet to become electron dense. Parallel studies of mitochondrial morphology in pcd cerebellum yielded further evidence for mitochondrial histopathology. As a number of studies have implicated (macro)autophagy in the selective removal of damaged mitochondria, a process referred to as ''mitophagy'' (Kim et al., 2007) , we have evaluated the role of autophagy in pcd neurodegeneration and recently published evidence for autophagy activation and mitophagy in degenerating pcd Purkinje neurons (Chakrabarti et al., 2009 ). Taken together with our current findings, we propose that disrupted bioenergetics function in pcd mice promotes neuron cell death, and this process may involve engagement of the mitophagy pathway, supporting two alternative models of Nna1-induced neuron cell death: one in which the bioenergetics collapse initiates the process ( Figure S5A ), and one in which increased mitochondrial turnover is the primary event ( Figure S5B ). Considerable evidence exists for both of these models. In support of the former model, human genetics studies have shown that mutations in mitochondrial genes, encoding components of the oxidative phosphorylation pathway, underlie a class of disorders characterized by retinal degeneration and cerebellar ataxia (Schon et al., 2001) , and mutations in nuclear genes functioning in the mitochondria comprise a class of autosomal-recessive spinocerebellar ataxias (Kaplan, 2002) . However, an independent line of investigation also suggests that altered mitochondrial turnover can drive neuronal demise, as mitochondria are extremely dynamic organelles engaged in a constant process of fission and fusion (Detmer and Chan, 2007) , and mitochondrial dynamics is inextricably tied to the process of mitophagy (Twig et al., 2008) . Although we do not yet understand how mitochondrial dynamics regulates function via the mitophagy pathway, mutations in genes encoding mitochondrial fission and fusion proteins produce neurodegenerative phenotypes, including Purkinje cell degeneration and retinal degeneration in mice and humans (Chen et al., 2007; Knott and Bossy-Wetzel, 2008) . In Parkinson's disease produced by loss of function of PTEN-induced kinase 1 (PINK1), complex I deficiency and increased mitophagy are observed (Dagda et al., 2009) , as in pcd neurodegeneration. A number of studies have attributed mitochondrial dysfunction in PINK1-deficient cells to impaired turnover of damaged mitochondria, while others have proposed that PINK1 deficiency promotes excessive mitophagy leading to the mitochondrial dysfunction (Abeliovich, 2010; Chu, 2010) . Hence, understanding the mechanistic basis of pcd neurodegeneration could clarify the relationship between mitochondrial damage and mitochondrial quality control in neurons, with implications for neurodegenerative disorders characterized by mitochondrial dysfunction, such as Parkinson's disease.
EXPERIMENTAL PROCEDURES
Fly Husbandry and Transgenic Fly Lines All flies were maintained at ambient temperature (22 C-23 C) on standard corn meal-molasses agar. Transgenic flies were generated by coinjection into w1118 embryos with pTurbo, using a well-established, standard protocol. We derived viable NnaD PL90 excision alleles by crossing with Delta 2-3 flies, selecting against mini-w+ and analyzing the resultant alleles by PCR amplification of the original P element insertion site. To construct the NnaD.GAL4 transgene, we amplified an 1.3 kb fragment of the Drosophila NnaD 5 0 promoter sequence with primers containing EcoRI and Not I tails (5 0 -gtacgcg aattcgctgacggtatctcgggcgt gttgttgctgc-3 0 and 5 0 -tgcatcgcggccgcctagctctct cgctccgccatcttggatggatgc-3 0 ) and cloned this fragment into pCR2.1 (Invitrogen). This fragment was then subcloned into the pG4PN vector. To derive the UAS.NnaD-RB transgene, we performed RT-PCR to amplify the NnaD-RB transcript into cDNA and subcloned it into pUAST. All plasmids were sequenced for verification. All Drosophila stocks not created in this study were obtained from the Bloomington stock center or the Vienna Drosophila RNAi Center, including the NnaD RNAi fly line (GD7301; transformant ID# 38508).
Mouse Transgenesis and Characterization
Using a PCR cloning approach, we generated a 5x-myc tagged mouse Nna1 transgenic cDNA which we subcloned into the pCX vector (Okabe et al., 1997) .
The wild-type 5x-myc tagged Nna1 cDNA was inserted at the multiple cloning site just 3 0 to the CMV enhancer-chick b-actin promoter (CAGGS). In a subsequent step, we used PCR mutagenesis to introduce nucleotide alterations into the Nna1 coding sequence, yielding an H912A-E915A (mutant zinc coordination; MuZn) version of the pCX-5x-myc-Nna1 transgenic vector. Both the pCX-5x-myc-Nna1 wt and pCX-5x-myc-Nna1-MuZn vectors were prepared for microinjection and used to derive independent lines of 5x-myc-Nna1 transgenic mice. Founders were identified by PCR amplification of vector sequences, and independent transgenic lines for the -wt and -MuZn versions of 5x-myc-Nna1 were established, based upon RT-PCR and western blot demonstration of transgene expression.
Northern Blot Analysis
One microgram of poly-A+ RNA was separated by agarose gel electrophoresis, transferred to Immobilon Ny+ membranes (Millipore), blocked, hybridized, and washed. An 100 bp fragment of the NnaD cDNA sequence was nick-translated with 32 P-dATP and used as the probe. Filters were washed and exposed to Kodak BioMax MR film for 5-7 days.
RT-PCR Analysis
Total RNA was purified from whole adult flies or third instar larvae by flashfreezing on dry ice, homogenizing in QIAGEN RT buffer (10 ml/sample), binding, and washing, as specified by the QIAGEN RNAeasy kit instructions. We synthesized cDNA with an anchored oligo-dT primer and AMV reverse transcriptase.
Mitochondrial Studies
Approximately 500 flies were chilled at 4 C for 30 min, then lightly crushed in a mortar and pestle, and collected in 5 volumes of isolation buffer (100 mM KCL, 50 mM Tris base [pH 7.8], 5 mM MgSO 4, 1 mM ATP, 1 mM EGTA, 0.5% BSA). The paste was homogenized in a 10 ml Teflon/glass Potter Elvehjem tissue grinder attached to a drill press for seven to eight strokes. The crude lysate was centrifuged (150 3 g) at 4 C for 10 min. The postnuclear supernatant was filtered through 200 mm nylon mesh and centrifuged at 3000 3 g for 10 min to generate a crude mitochondrial pellet. This pellet was suspended in 210 mM mannitol, 70 mM sucrose, 5 mM HEPES (pH 7.2), 1 mM EGTA, and 0.5% BSA and centrifuged again at 3000 3 g to generate the heavy mitochondrial fraction. The supernatant of the first spin was centrifuged at 9000 3 g to generate a lighter mitochondrial fraction, and the supernatant of this spin was referred to as the postmitochondrial supernatant. Mouse liver submitochondrial fractions were generated as previously described (Wiley et al., 2009) , with minor modification. The hypo-osmotic swelling of purified mitochondria was allowed to proceed for 10 min followed by DOUNCE homogenization to release outer membrane fragments. Mitochondria were purified for biochemical assays by homogenizing in a glass Dounce homogenizer and pestle in cold homogenization buffer (50 mM Tris-Cl, 100 mM KCl, 1.5 mM MgCl 2 , 1 mM EGTA, 50 mM HEPES, 0.25 M sucrose, protease inhibitors [pH 7.4]). The homogenate was spun at 1000 3 g for 5 min at 4 C, and the pellet was resuspended in buffer, and recentrifuged. Supernatants were pooled and spun at 10,000 3 g for 25 min at 4 C. The pellet was resuspended in homogenization buffer, and both the supernatant and resuspended pellet were recentrifuged. Supernatants were pooled, aliquoted into small fractions, and snap-frozen on dry ice. Complex I NADH-coenzyme Q reductase, complex II succinate dehydrogenase, and complex V F1-ATPase assays were performed as previously described (Gassner et al., 1997; Janssen et al., 2007) .
Enzyme Assays
Extracts were prepared from whole tissue lysates of 8-week-old pcd 5J and littermate control retinas (n = 3 mice/sample). We assayed phosphoglycerate mutase activity and pyruvate kinase activity based on http://www. sigmaaldrich.com/content/sigma-aldrich/areas-of-interest/life-science/ metabolomics/enzyme-explorer/learning-center/assay-library.html. Please see Supplemental Information for the following experimental procedures: antibody generation, western blot analysis, immunohistochemistry, electron microscopy, Drosophila behavioral and toxicity assays, and proteomics methods. 
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